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Glomerulonephritis (GN) is still the most common cause of
end-stage renal disease. Accumulation of glomerular
macrophages, proliferation of mesangial cells, and deposition
of extracellular matrix proteins are pathobiological hallmarks
of GN. Pharmacological interventions that can inhibit these
insults may be beneficial in the retardation of the
progression of GN. Honokiol originally isolated from
Magnolia officinalis, shows antioxidative, anti-inflammatory,
and antiproliferative activities in a variety of inflammation
models. In this study, we first investigated the in vivo effects
of honokiol on rat anti-Thy1 nephritis. Anti-Thy1 nephritis
was induced in Wistar rats by injecting mouse anti-rat Thy1
antibodies intravenously. Nephritic rats were randomly
assigned to receive honokiol (2.5 mg/kg, twice a day) or
vehicle and were killed at various time points. Glomerular
histology and immunohistopathology and urine protein
excretion were studied. Western blotting was conducted for
markers of proliferation. Adhesion molecules, chemokine,
and extracellular matrix gene expression were evaluated by
Northern blotting. Honokiol-treated nephritic rats excreted
less urinary protein and had lower glomerular cellularity and
sclerosis. The increased intraglomerular proliferating cell
nuclear antigen and Akt phosphorylation in nephritic rats
could be abolished by the treatment of honokiol. Honokiol
also alleviated glomerular monocyte chemoattractant
protein-1 and intracellular adhesion molecule-1, similar to
type I (a1) collagen and fibronectin mRNA levels of nephritic
rats. These results indicate that honokiol may have
therapeutic potential in mesangial proliferative GN.
Kidney International (2006) 70, 682–689. doi:10.1038/sj.ki.5001617;
published online 28 June 2006
KEYWORDS: honokiol; anti-Thy1 glomerulonephritis; monocyte chemoat-
tractant protein-1; extracellular matrix; Akt phosphorylation
Glomerulonephritis (GN) is still the most common cause of
end-stage renal disease.1 GN is an immune-related inflam-
matory disease of glomeruli characterized by inflammatory
cell infiltration, excess glomerular cell proliferation, and
mesangial matrix deposition in response to phlogistic stimu-
lation.2,3 During disease progression, the roles of numerous
adhesion molecules, chemokines, and growth factors, such as
intracellular adhesion molecule-1 (ICAM-1), monocyte
chemoattractant protein-1 (MCP-1), and platelet-derived
growth factor (PDGF), can further drive the above patho-
logical changes.4–6 Phosphatidylinositol 3-kinase–Akt path-
way transmits platelet-derived growth factor signaling to
regulate the expression of cell cycle proteins to promote cell
cycle progression in mesangial cells (MCs), which are the
major components of glomerular cell proliferation.7 Phar-
macological interventions that can inhibit the inflammation,
the proliferation of glomerular cells, and/or matrix deposi-
tion thus may be beneficial in the retardation of the
progression of GN.
Honokiol (HK) (4-allyl-2-(3-allyl-4-hydroxy-phenyl)-
phenol), a traditional medicine, is isolated from the cortex
of Magnolia officinalis, which has been used for digestive
complaints and anxiety-related disorders in China and Japan.
The pharmacological effects of HK include inhibition of
platelet aggregation,8,9 protection of the myocardium against
ischemic injury,10 suppression of ventricular arrhythmia,11
and induction of myeloma cells apoptosis.12 In vitro studies
have demonstrated that HK inhibits tumor necrosis factor-a-
stimulated nuclear factor-kappa B activation, which plays
a key role in angiogenic and proliferative activities of tumor
development.13 In in vivo models, HK has been shown to
protect against focal cerebral ischemia–reperfusion injury by
inhibiting neutrophil infiltration and reactive oxygen species
(ROS) production,14 halting the fibrotic process by inducing
apoptotic death in activated rat hepatic stellate cells.15 To
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date, however, the therapeutic effects of HK in renal disease
have never been reported. The aim of the present study was
to investigate the in vivo therapeutic effects of HK on
the markers of GN progression, including the severity of
proteinuria, glomerular Akt phosphorylation, adhesion
molecules, chemokine, and extracellular matrix gene
expression.
The anti-Thy1 experimental nephritis is a well-established
rat experimental mesangioproliferative GN model that is
characterized by Thy1 antibody, specific bindings to MCs
mediating complement-induced mesangiolysis, which is
followed by rebound MC proliferation starting on day 2,
peaking on day 4/5, and ceasing afterward.16–19 Apoptosis has
also been observed as an important factor, contributing to the
resolution of rebound MC proliferation.20 This experimental
model acts as a good model of acute GN and offers a unique
opportunity to evaluate the possible therapeutic implications
of novel pharmacological compounds on GN. Thus, the ex-
perimental animal model was chosen to test the therapeutic
effects of HK on GN.
Our current study determines that HK attenuates the
proteinuria levels of Thy1 nephritis in rats. Furthermore, we
identified that the inhibition of Akt phosphorylation may, at
least partially, suppress rebound glomerular cell proliferation
by demonstrating that HK inhibits glomerular proliferating
cell nuclear antigen (PCNA) protein levels. Our data show
that HK diminishes the severity of inflammation and
glomerulosclerosis by the inhibition of adhesion molecules,
chemokines, and matrix gene expression, but has no influ-
ence on glomerular cells apoptosis.
RESULTS
Effect of HK treatment on proteinuria of anti-Thy1 nephritis
Three groups of rats were studied as listed in Figure 1. During
the study course, no adverse effects were observed for animals
clinically. Body weight, fluid intake, and urinary volume
among the three groups of rats were equal (data not shown).
As shown in Figure 2, the urinary total protein/creatinine
ratio was determined for each rat. These three groups had
similar levels of urinary protein excretion ratios before the
injection of anti-Thy1 antibodies (data not shown). Com-
pared with control rats (group A), anti-Thy1 nephritic rats
(group B) demonstrated frank proteinuria (more than a
15-fold increase) in the fifth day of nephritis. The group C
nephritic rats, in which HK was administered immediately
before nephritis induction, showed a significant reduction in
urinary protein excretion compared with group B rats. At the
end of the experiment, plasma creatinine and calculated
creatinine clearance did not differ among three groups (data
not shown).
Effect of HK treatment on glomerular histology
Renal cortical tissue from anti-Thy1 nephritic rats (group B)
showed prominent mesangial hypercellularity and glomerular
sclerosis on periodic acid-Schiff/hematoxylin–eosin-stained
sections on the fifth day of nephritis. In contrast, in
anti-Thy1 nephritic rats treated with HK (group C), the
histological changes were significantly attenuated (Figure 3
and Table 1). When evaluated semiquantitatively, anti-Thy1
nephritic rats (group B) had the highest glomerular sclerosis
score over HK-treated nephritic rats (group C) of nephritis.
The percentage of glomeruli displaying moderate or severe
matrix expansion was 0% in group A, 73.5% in group B, and
31.5% in group C. Similarly, the total glomerular cell number
of nephritis was fewer in the HK treatment group (group C,
67.270.9 per glomeruli) than in the anti-Thy1 nephritic
group (group B, 82.570.9 per glomeruli).
Effect of HK treatment on MCs and glomerular macrophages
As shown by Chen et al.,18 the induction of anti-Thy1
nephritis resulted in activation and proliferation of MCs
beginning at day 3, sustaining well into day 5 of nephritis.
The activated MCs (a-smooth muscle actin (SMA) positive)
at day 5 were reduced significantly by HK (group C; 33%;
Figures 3 and 4a). Furthermore, the influx and accumu-
lation of circulating macrophages began as early as 2 h
Anti-Thy1 Ab
(1.5 mg/kg)
30 min Day 1 Day 5
HK
(2.5 mg/kg, twice a day)
Killed Killed
(n = 4, each group)
Urine protein/creatinine– –
–
+
++
Group A
Group B
Group C
Histology
Immunohisto chemistry
Immunofluorescence
Glomerular isolation
Western blots
Northern blots
Figure 1 | Schematic representation of induction of anti-Thy1
nephrotic rats. Control rats (group A); vehicle-treated anti-Thy1
nephritic rats (group B); and HK-treated anti-Thy1 nephritic rats
(group C).
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Figure 2 | Effects of HK on urinary protein excretion of anti-Thy1
nephritis at day 5. Control rats (group A); vehicle-treated anti-Thy1
nephritic rats (group B); and HK-treated anti-Thy1 nephritic rats
(group C) (n¼ 4 for each group). Urinary total protein/creatinine ratio
was determined for each rat. Data are presented as mean7s.e.m.
for each group. *Po0.01 versus control rats (A). **Po0.01 versus
vehicle-treated anti-Thy1 nephritic rats (B).
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with maximal accumulation at day 1 after the induction of
nephritis.18 Treatment with HK (group C) significantly
reduced the number of mouse anti-rat monocyte/macro-
phage antibody (ED-1) positive cells in 25.1%, as shown in
Figures 3 and 4b.
Effect of HK treatment on glomerular proliferation and
apoptosis
As shown in Figure 5, glomerular PCNA was upregulated
in anti-Thy1 nephritic rats (group B) at day 5. Treatment
with HK (group C) attenuated the protein levels of PCNA,
which indicates that HK inhibits glomerular cell proliferation
in vivo. Taking into consideration phosphatidylinositol
3-kinase/Akt activation involved in cell survival and proli-
feration, we examined the involvement of Akt in experi-
mental anti-Thy1 nephritic rats. A significant diminishment
of Akt phosphorylation was shown after treatment with anti-
Thy1 antibody, as shown in Figure 5. This result indicates
that HK can inhibit glomerular cell proliferation through the
modulation of Akt signaling pathway. The effects of HK on
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Figure 3 | HK ameliorated the glomerular sclerosis, mesangial
proliferation, and macrophage accumulation in Thy1 nephritis
rats. Light microscopy of the pathology and immunopathology
of the glomeruli is shown. Periodic acid-Schiff stain was carried
out for the detection of glomerular sclerosis and immunostaining
with a-SMAþ for activated MCs and ED-1þ for accumulated
macrophages. Cells positive for specific antigen were brown-stained.
In comparison with Thy1 nephritis rats (Group B), HK-treated
nephritis rats (Group C) reduced the glomerular sclerosis and cells
expressing a-SMA at day 5 and ED-1 at day 1. The results of the
assessment are shown in Table 1 and Figure 4. Original
magnification:  200.
Table 1 | Effects of HK on total glomerular cells and
glomerular sclerosis scores in anti-Thy1 nephritic rats
Group A Group B Group C
Total glomerular cells 60.670.6 82.570.9a 67.270.9a,b
Glomerular sclerosis
Grade 0 198 (99.0) 2 (1.0) 19 (9.5)
Grade 1 2 (1.0) 51 (25.5) 118 (59.0)
Grade 2 0 56 (28.0) 51 (25.5)
Grade 3 0 91 (45.5) 12 (6.0)
Total scores 2 436 256
HK, honokiol.
The groups are defined as follows: group A, control rats; group B, anti-Thy1 nephritic
rats; group C, treated with HK from day 1 to 5 of nephritis. Values for total
glomerular cells are presented as mean7s.e.m., and values for glomerular sclerosis
represent the number of glomeruli in each group (numbers in parentheses denote
percentages of glomeruli). For experimental protocol and grading of sclerosis, see
the Materials and Methods section). A total of 200 glomeruli were examined from
each group of four rats (50 glomeruli per animal).
aPo0.01, relative to group A.
bPo0.01, relative to group B.
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Figure 4 | Effects of HK on MC activation and macrophage
accumulation. (a) Activated MCs (a-SMA-positive) at day 5, and
(b) accumulated glomerular macrophages (ED-1 positive) at day 1
in a rat with anti-Thy1 nephritis. Control rats (group A); vehicle-
treated anti-Thy1 nephritic rats (group B); and HK-treated anti-Thy1
nephritic rats (group C). *Po0.01 versus control rats (A). **Po0.01
versus vehicle-treated anti-Thy1 nephritic rats (B).
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Figure 5 | Representative Western blots demonstrating the
effects of HK on glomerular proliferation markers. Akt
phosphorylation and PCNA protein levels of Thy1 nephritis
were demonstrated at day 5 of disease induction. Control rats
(group A); vehicle-treated anti-Thy1 nephritic rats (group B); and
HK-treated anti-Thy1 nephritic rats (group C).
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MC apoptosis were examined next. Thy1 nephritis rats with
or without HK treatment showed no difference in the ratio of
terminal transferase-mediated dUTP nick end-labeling-posi-
tive and 40,6-diamidine-20-phenylindole dihydrochloride-
positive nuclei in all fields examined (12.575.2 versus
12.077.5 per 50 glomerular cross-section, P40.05).
Effect of HK treatment on glomerular mRNA expression
As shown in Figure 6, glomerular mRNA expression of
ICAM-1 and MCP-1 was upregulated in anti-Thy1 nephritic
rats (group B) at day 1. Treatment with HK (group C)
attenuated the augmented expression of both genes. The
induction of anti-Thy1 nephritis upregulated the glomerular
mRNA expression of type I (a1) collagen, as well as fibro-
nectin at day 5. Treatment with HK (group C) diminished the
augmented expression of the matrix genes studied.
DISCUSSION
This study demonstrates that HK, a small molecular weight
natural product, attenuates anti-Thy1 nephritis through its
effects against cell proliferation, inflammation, and fibrosis.
To the best of our knowledge, this is the first study
demonstrating that HK may have potential therapeutic
effects on GN. There are several reasons explaining how
HK preserves renal pathologic insults in experimental GN.
First, proteinuria has been well known for its harmful effects
of tubulointerstitial damage through the effects of excessive
reabsorption and lysosomal degradation of proteins, the
direct effects of toxic compounds, and the secondary effects
of proinflammatory and profibrotic mediators produced by
tubular cells. The resulting inflammation/fibrosis is supposed
to be responsible for the loss of nephrons.21 In this work, the
ability of HK to diminish proteinuria in acute Thy1 nephritis
may have significant clinical importance. However, does
HK attenuate proteinuria in chronic anti-Thy1 glomerulo-
sclerosis or other renal fibrosis models deserve further
investigation?
Mesangial proliferative GN is characterized by excessive
MC proliferation and extracellular matrix accumulation,
which leads to glomerular sclerosis and obliteration, in
turn, deteriorating renal function. As shown in Figure 3 and
Table 1, the percentage of glomeruli exhibiting more severe
histological changes (grade 3 and 4) is higher in group B
(73.5%) than in group C (31.5%). As proteinuria often
heralds activation of GN and subsequent progression toward
glomerular sclerosis, the ability of HK to suppress proteinuria
and attenuate the pathological severity may have profound
clinical importance.
In many human and experimental forms of GN,
infiltration of monocyte and macrophage into the glomer-
ulus has been implicated in the initiation of glomerular
injury.18,22 The mechanism of monocytes migrating to sites
of renal injury is related to multiple factors.23,24 Recent
studies suggest that adhesion molecules such as ICAM-1 that
are present on the capillary endothelium, monocytes, and
MCs, as well as chemokines such as MCP-1 secreted by
monocyte and macrophage, might contribute to the recruit-
ment of monocytes.4,5 This study demonstrates that anti-
Thy1 nephritis rats exhibit high levels of glomerular ICAM-1
and MCP-1 mRNA during the acute phase of anti-Thy1
disease (Figures 3 and 6a), corresponding to the accumula-
tion of macrophages in the glomerulus. Because treatment
with HK reduced the enhanced glomerular mRNA expression
of both ICAM-1 and MCP-1, it is conceivable that by
reducing the expression of these molecules, the recruitment
of monocytes into the glomerulus was also diminished.
Furthermore, ROS have been shown to mediate increased
glomerular protein permeability in isolated glomeruli.25
Previous reports suggest that MCP-1 serves not only as a
chemoattractant but also activates monocyte superoxide
anion and hydrogen peroxide production.26 Thus, one
possible mechanism for the reduction of proteinuria by HK
might involve either suppression of glomerular macrophage
accumulation or inhibition of MCP-1 production by
macrophages. In a rat ischemia/reperfusion cerebral injury
model, Liou et al.27 elucidated the anti-inflammatory ability
of HK by demonstrating it as a potent ROS inhibitor/
scavenger through modulating enzyme systems related to
ROS production or metabolism, including nicotinamide
adenine dinucleotide phosphate (reduced form) oxidase,
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Figure 6 | Representative Northern blots demonstrating the
effects of HK on glomerular mRNA level expression. (a) MCP-1
and ICAM-1 on day 1 of disease induction; and (b) type I (a1) collagen
and fibronectin-1 in rats with anti-Thy1 nephritis on day 5. Control
rats (group A); vehicle-treated anti-Thy1 nephritic rats (group B);
and HK-treated anti-Thy1 nephritic rats (group C).
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myeloperoxidase, cyclooxygenase, and glutathione sulfhydryl
peroxidase in neutrophils. These findings may explain, at
least partially, the mechanism of HK attenuation of anti-Thy1
nephritis through the direct inhibition of ROS generation in
monocyte and macrophage and the indirect effect of MCP-1.
In addition, several reports in the literature suggest that
the anti-inflammatory ability of HK is modulated by the
inhibition of nuclear factor-kappa B-related gene expres-
sion.13 This finding has also been elucidated in our recent
work on mesnagial cells (unpublished data).
MC proliferation is a characteristic feature of many
forms of glomerular diseases including IgA nephropathy,
lupus nephritis, and mesangial and membrano-proliferative
GN, and is closely linked to matrix expansion.28 Numerous
studies have attempted to suppress MC proliferation by
inhibiting specific mitogens.7,18 In this work, we successfully
demonstrated that HK attenuates glomerular hypercellularity
by producing a lower total glomerular cell number
(hematoxylin–eosin stain) and PCNA protein (immunoblot-
ting), as shown in Figures 3 and 5, and Table 1. Indeed, HK
has been shown to inhibit proliferation of several cell types in
culture, including transformed endothelial cell line SVR
(SVEN 1 ras), human colorectal cell line RKO (ATCC, CRL-
2577), and human lymphoid leukemia Molt 4B.29–31 Media-
tion of myofibroblast transformation of MCs in anti-Thy1
nephritis likely involves several mechanisms, which incor-
porate a wide array of cytokines and growth factors secreted
by infiltrating macrophages and resident glomerular cells,
primarily MCs.24,32 This study further demonstrates that
HK in vivo reduced the number of macrophages in the early
phase of nephritis and also decreased the number of activated
MCs (a-SMA positive) on day 5. Recently, we demonstrated
that MC proliferation is modulated by a phosphatidylinositol
3-kinase/Akt-dependent pathway in a high-glucose and
inflammatory condition.33,34 In agreement with this notion,
we demonstrated that HK reduced glomerular Akt phospho-
rylation triggered by anti-Thy1 antibody in nephritic rats.
These findings may partially explain the pharmacological
mechanism of HK-inhibited glomerular cell proliferation.
The present data did not suggest that HK induces glomerular
cell apoptosis in Thy1 nephritis rats. A previous work by
Ishitsuka et al.12 demonstrated that HK overcomes conven-
tional drug resistance in human multiple myeloma by
induction of caspase-dependent and -independent apoptosis.
However, Zhai et al.35 suggested that HK-induced neurite
outgrowth promotion depends on activation of extracellular
signal-regulated kinases 1 and 2. The above observation
evidenced that the effects of HK treatment on cell prolifera-
tion and apoptosis are opposite in different cell types.
Because MCs are responsible for the production of a
variety of extracellular matrix proteins within the glomer-
ulus,36,37 suppression of their activation and proliferation
may contribute significantly to the amelioration of glomer-
ular sclerosis. Our data show a normalization of type I (a1)
collagen and fibronectin mRNA expression by HK treatment
up to day 5, as shown in Figure 6b. We cannot exclude the
effects at later time points. In anti-Thy1.1 nephritis, collagen
I mRNA expression preceded the appearance of type I
collagen protein for several days. Collagen protein accumula-
tion is modulated by production as well as degradation of
collagen. At least the transcriptional regulation of collagen
production was clearly attenuated by HK. Acute anti-Thy1.1
nephritis is well suited to study changes in mesangial
proliferation, but it is limited in the analysis of fibrosis.
Future studies of HK treatment in chronic anti-Thy1.1
nephritis could help to answer the question of whether or not
HK treatment has antifibrotic properties in this model.
A single dose of 250 mg/kg HK administered intra-
peritoneally yielded maximum plasma concentration of
43.5 mM with an elimination half-life of 5.2 h.38 After
multiple doses of 2–3 mg/mice at 1- to 2-day intervals, HK
was shown effective in the inhibition of tumor growth in
vivo.29,38 Although the dosages of HK used in our studies are
slightly higher than the previous works, there are no observed
renal, hepatic, and other adverse effects detected (data not
shown). HK reduces the number of activated MCs, which is
the major source of matrix proteins in the glomeruli.
However, the inhibitory effects of HK on the number
of activated MCs (33%) is less than the expression of matrix
gene mRNA levels (72.5% for type I collagen and 66.7%
for fibronectin), as shown in Figures 3, 4a, and 6b. We
speculate that the discrimination may be explained by the
fact that HK reduces the glomerular mRNA levels of collagen
and fibronectin as a result of the suppression of transcrip-
tional activity and/or mRNA stability. The role of HK on MC
matrix gene expression deserves further investigation, and
this work is currently underway by our team.
In summary, this study demonstrates that the clinically
applicable Chinese medicine HK attenuates proteinuria,
reduces accumulation of glomerular macrophages, suppresses
proliferation of MCs, and ameliorates glomerular sclerosis in
rats with anti-Thy1 disease. The mechanism by which HK
acts might be, at least in part, ascribed to its ability to
suppress glomerular ICAM-1 and MCP-1 mRNA levels in the
early phase, inhibiting mesangial hypercellularity and extra-
cellular matrix protein mRNA levels in the middle phase of
nephritis. These results suggest that administration of HK
in vivo may have promise as an anti-inflammatory, anti-
proliferative, and antifibrotic agent in the treatment of the
acute phase of mesangial proliferative GN. Whether HK can
be applied to relapses or chronic GN deserves further
investigation.
MATERIALS AND METHODS
Disease model and experimental protocol
Male Wistar rats weighing 180–200 g were obtained from the animal
center of the College of Medicine, National Taiwan University. Three
groups of rats were studied as listed in Figure 1. The control rats
(group A, N¼ 4) received only 0.2 ml of 1 phosphate-buffered
saline (PBS; pH 7.4) at the beginning of day 1. The nephritic rats
(group B, N¼ 4) received 1.5 mg/kg of a mouse anti-rat Thy1
(CD90) monoclonal antibody (lyophilized ascites; Cedarlane,
Ontario, Canada) in 0.2 ml of 1PBS at the beginning of day 1
686 Kidney International (2006) 70, 682–689
o r i g i n a l a r t i c l e C-K Chiang et al.: Honokiol alleviates anti-Thy1 nephritis
and were treated with vehicle (1PBS) from day 1 to day 5. Group
C rats were treated with the same dose of anti-Thy1 antibody as
group B, plus HK (2.5 mg/kg, twice a day) from day 1 to day 5
(group C, N¼ 4). Anti-Thy1 antibody was given by intrajugular
venous injection, whereas HK and vehicle were administered by
intraperitoneal injection.18 All animals in groups A–C were killed at
the end of day 1 and day 5 of nephritis. The choice of timing to
perform animal killing was based on the suggestion of Chen et al.,18
who demonstrated that the peak of ICAM-1 and MCP-1 gene
expression is at day 1, and the maximal expression of matrix genes,
including type I (a1) collagen and fibronectin genes, is at day 5.
Therefore, all data in this work are from the findings of day 5,
although the immunohistochemical staining for ED-1 and Northern
blotting for ICAM-1 and MCP-1 are from findings after 1 day of
nephritis induction. HK standard compound derived from the M.
abovata with greater than 99.0% purity detected by liquid
chromatogram was purchased from Wako Pure Chemical Industries
Ltd, Osaka, Japan. The investigation complied with the standards
delineated in the Guide for the Care and Use of Laboratory Animals,
published by the US National Institutes of Health (Bethesda, MD,
USA).
Renal glomerular histopathology
Tissues for glomerular histology were fixed in 10% formalin, and
6 mm paraffin sections were stained with periodic acid-Schiff and
hematoxylin–eosin reagent. The percentages of glomeruli exhibiting
segmental/global sclerosis were assessed by examination of 50
glomeruli, with similar cross-sectional diameters, per animal, graded
on a scale of 0–3 as follows: grade 0 (normal, no positive stains per
glomerulus); grade 1 (mild changes, o25% positive stains
per glomerulus); grade 2 (moderate changes, 25–50% positive stains
per glomerulus); and grade 3 (severe changes, 450% positive
stains per glomerulus). Glomerular sclerosis was scored semiquan-
titatively in each group of animals by multiplying the scale (ranging
from 0 to 3) by the number of glomeruli, and total scores were
calculated by the sum of individual products in each group of four
rats. Glomerular hypercellularity was assessed on the basis of total
glomerular cells per glomerular cross-section. Two hundred
glomeruli (50 glomeruli per animal) were counted for each group
of four rats. Calculations of the cell number and sclerotic scores were
performed in a blinded fashion using coded samples until the
analysis was completed.18
Immunohistochemical staining
Frozen tissue sections were used for immunoperoxidase staining.
Briefly, after perfusing the heart with 150 ml of ice-cold 1PBS, rat
kidneys were removed and cut coronally into 4 mm thick slices and
immersed in 4% paraformaldehyde immediately at 41C overnight.
The next day, paraformaldehyde solutions were decanted, and the
tissues were immersed in 30% sucrose at 41C overnight. Tissues
were then embedded in Tissue-Teks 2,2-oxacalcitriol compound
(Miles Inc., Elkhart, IN, USA) in isopentane in liquid nitrogen and
stored at 701C until cryostat sectioning.
Immunohistochemical staining was performed by staining the
sections for either a mouse anti-rat ED-1 (monocytes/macrophages)
monoclonal antibody (Chemicon, Temecula, CA, USA) or a mouse
anti-rat a-SMA monoclonal antibody (Sigma, St Louis, MO, USA).
Briefly, 6 mm renal sections were microwaved (model Tatung TMO-
6810) in 0.01 M citrate buffer, pH 6.0, for 2–5 min periods at 800 W
to retrieve the antigens. The sections were then treated with 0.5%
hydrogen peroxidase in 1PBS for 20 min at room temperature to
block the endogenous peroxidase. Sections were subsequently
blocked with 10% normal goat serum for 30 min at room
temperature, and primary antibodies were then added followed by
incubation at 41C overnight. The following day, sections were
washed three times in 1PBS/0.1% Triton X-100 for 10 min and
were incubated with biotin-conjugated anti-mouse or anti-rabbit
IgG for 1 h at room temperature. The sections were then incubated
with the avidin–biotin–peroxidase reagent for another 1 h at room
temperature according to the manufacturer’s instructions (Dako-
patts, Glostrup, Denmark). The reactions on sections were detected
with peroxidase substrate containing diaminobenzidine chromogen
enhanced with 1.5% ammonium nickel sulfate (for ED-1 and a-
SMA staining). For the negative controls, the specific antibodies
were omitted. Cells were identified as macrophages if they showed
positive membrane staining for ED-1. Cells were identified as MCs if
they showed cytoplasmic staining for a-SMA. Calculation of the cell
number was performed in a blinded fashion using coded samples
until the analysis was complete.
Immunofluorescence staining for apoptosis
Tissues for glomerular immunofluorescence staining were fixed in
10% formalin, and 8mm paraffin sections were stained with terminal
transferase-mediated dUTP nick end-labeling reagent (Promega,
Madison, WI, USA) and 40,6-diamidine-20-phenylindole dihy-
drochloride for in situ apoptosis detection. In brief, 8mm frozen
sections were treated with 20mg/ml proteinase K and then incubated
in a nucleotide mixture containing fluorescein-12-dUTP and terminal
deoxynucleotidyl transferase. Positive controls were pretreated with
1 U/ml DNAse, and negative controls were incubated without
terminal deoxynucleotidyl transferase in the oral cancer cells.
Terminal transferase-mediated dUTP nick end-labeling-positive
nuclei were expressed as total positive staining cells per 50 glomerular
cross-sections. Two hundred glomeruli (50 glomeruli per animal)
were counted for each group of four rats in a blinded fashion.
Glomeruli isolation and immunoblotting
Renal glomeruli were isolated at various time points after nephritis
induction by graded sieving (250, 150, and 75 mm). The purity of the
preparations was checked to ensure that there was less than 5%
tubular contamination in each glomerular preparation. The glo-
meruli lysates were prepared as described previously.33 An 80-mg
sample of each cell lysate was subjected to electrophoresis on 10%
sodium dodecyl sulfate polyacrylamide gels. The samples were then
electroblotted on polyvinylidene difluoride membranes. After
blocking, blots were incubated with anti-PCNA, anti-b-actin (Santa
Cruz Biotechnology Inc., Santa Cruz, CA, USA), anti-Akt, and anti-
phospho-Akt (New England BioLabs Inc., Beverly, MA, USA)
antibodies in PBST (PBS within 0.1% Tween 20) for 1 h followed
by two washes (15 min each) in PBST. The membranes were
then incubated with horseradish peroxidase-conjugated secondary
antibodies for 30 min. Enhanced chemiluminescence reagents
(Amersham Pharmacia Biotechnology) were employed to depict
the protein bands on membranes.
Northern blot analysis
Renal glomeruli were isolated by graded sieving as described in the
previous section. Total RNA was isolated from the glomeruli by the
acid guanidinium thiocyanate–phenol–chloroform method.39 Ten
micrograms of total RNA was electrophoresed on formaldehyde-
denatured 1% agarose gels and subsequently transferred to nylon
membranes according to standard protocols. Hybridization was then
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performed with digoxigenin-labeled RNA probes (method des-
cribed later in this article). The blots were developed using CSPDs
(Boehringer Mannheim, Mannheim, Germany) as the substrate
for alkaline phosphatase. The intensity of the signal was then quanti-
tated with computerized densitometry using the National Institutes
of Health Image Program on an Apple Macintosh computer and was
normalized against the signal of glyceraldehyde-3-phosphate
dehydrogenase or 18S RNA messages. All chemicals used for total
RNA isolation and Northern blot hybridization were of molecular
grade and were obtained from Sigma (St Louis, MO, USA) or
Boehringer Mannheim unless otherwise specified. For synthesis of
collagen and fibronectin RNA probes, cDNAs for human type I (a1)
collagens, and human fibronectin-1 were purchased from American
Type Culture Collection (Rockville, MD, USA). A 1.5-kb EcoRI
fragment of type I (a1) collagen and a 1.2-kb EcoRI fragment of
fibronectin cDNAs were subcloned into the pBSII/SK¯ vector
(Stratagene, La Jolla, CA, USA). For synthesis of rat ICAM-1 and
MCP-1 riboprobes, cDNA fragments were first generated by reverse
transcription-polymerase chain reaction from glomerular RNA of
anti-Thy1-injected rats, using the following specific primer pairs:
ICAM-1, upstream, 50-TCTCAGCAGACTCTTACATC-30 (corre-
sponding to bases 1300–1319) and downstream, 50-ATATCCT
GATCTTCCTCTGG-30 (corresponding to bases 1587–1606);40 and
MCP-1, upstream, 50-TCAGCCAGAT-GCAGTTAATG-30 (corre-
sponding to bases 108–127) and downstream, 50-TTCTCTGTCA
TACTGGTCAC-30 (corresponding to bases 463–482).41 The pro-
ducts were subsequently subcloned into the pGEM-dT vector
(Promega, Madison, WI, USA). The cloned cDNAs were then
linearized and used as templates for in vitro transcription of
antisense digoxigenin-conjugated riboprobes, following the suppli-
er’s instructions (Boehringer Mannheim).
Miscellaneous measurements
Serum samples were drawn out from the inferior vena cava before
PBS perfusion. Urine samples were collected from all rats living in
metabolic cages 24 h before killing. Total protein and creatinine
concentrations were analyzed with the automatic analyzer, Integra
800 (Roche, Mannheim, Germany). All analyses were performed
by the Department of Laboratory Medicine, National Taiwan
University Hospital.
Statistical analysis
Data are expressed as mean7s.e.m. and were compared using
one-way analysis of variance and the Bonferroni test. Values for
glomerular sclerosis represent numbers of glomeruli in each group
(numbers in parentheses denote percentages of glomeruli). All
statistical calculations were made with SPSS 10.0 for Windows.
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